altogether better

Integrated research compliance solutions to streamline your study

Get a Quote

75% of US-Based Operation Warp Speed  Vaccine Trials Overseen by Advarra IRB, IBC

Webinar: October 13

Study Startup Success: New Generation of Genetically Engineered Vaccines

Trust Advarra’s integrated solutions and collaborative approach to make your research altogether better.

Advarra® provides institutional review board (IRB), institutional biosafety committee (IBC) and GxP/HRP research compliance consulting services with unprecedented clarity.

Advarra recently acquired Forte, the market-leading provider of clinical technology solutions including OnCore. Learn more

Our Latest Updates

Discover What’s Happening at Advarra


Advarra Executive James Riddle Receives SRA International’s Best Concurrent Session Award

September 16, 2020

The Society of Research Administrators International (SRA International) has awarded James Riddle, Advarra VP of Institutional Services, its Best Concurrent Session Award.

Oct131 pm ET

Study Startup Success for the New Generation of Genetically Engineered Vaccines

The global COVID-19 pandemic has brought vaccine research to the forefront, and a surge of research involving genetically engineered vaccines is currently taking place. The availability of the viral genome…


Q&A – The New Urgency of Clinical Trials: How Oncology Leads the Evolution

September 28, 2020

In Advarra’s recent virtual symposium, experts from industry and academia met to discuss how oncology research has influenced agility in clinical trial design, particularly during the COVID-19 pandemic. Panelists talked…


2020 Fall Onsemble

October 6-9, 2020

Ready for Research Compliance Solutions That Are Altogether Better?

Get Started